Disease: Histoplasmosis

Recognizing the Importance of Public Health Mycology

mycolabadmin

This editorial highlights how fungal infections are a growing but overlooked global health crisis, killing about 2.5 million people annually. The paper brings together seven research articles studying different fungal diseases, from lung infections to skin conditions, showing how these diseases spread differently in different populations and how resistance to antifungal medications is increasing. The authors emphasize that better testing, treatment access, and worldwide disease tracking are urgently needed, especially in poorer countries where the burden of fungal disease is highest.

Read More »

Photo Quiz: A cutaneous fungal infection with discordant biomarker results—a diagnostic challenge

mycolabadmin

A woman with advanced HIV disease presented with unusual skin lesions that were initially suspected to be from a virus, but laboratory testing revealed a rare fungal infection called histoplasmosis caused by Histoplasma capsulatum. The case was challenging because some standard fungal tests came back negative even though the patient had the infection, showing why doctors need to rely on culture and examination under the microscope. She was treated with antifungal medications and her diagnosis highlights the importance of considering fungal infections in severely immunocompromised patients even when initial tests seem negative.

Read More »

Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate

mycolabadmin

Doctors and researchers use standard definitions to determine if antifungal treatments work in clinical trials. This debate examines whether the standards created in 2008 are still appropriate today. Key concerns include whether stable disease should always count as treatment failure, how to handle deaths from other causes, and whether newer testing methods should be incorporated. The expert panel concluded these definitions need updating to reflect modern treatment options and patient needs.

Read More »

Usefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Retrospective Comparative Analysis of Different Diagnostic Techniques and Quantification of Host Biomarkers

mycolabadmin

This study evaluated how well different blood tests can detect histoplasmosis, a serious fungal infection caused by Histoplasma capsulatum. Researchers compared three types of tests: those detecting fungal antigens, those detecting antibodies the body produces against the fungus, and DNA-based tests. They found that the best test depends on whether the patient’s immune system is functioning normally or is weakened by HIV, and using a combination of tests provides the most reliable diagnosis. The study also identified specific immune markers in the blood that are elevated in infected patients, which could help predict disease severity.

Read More »

Advancing Patient Advocacy in Mycology: Cultivating Collaboration in Education, Research, and Policy

mycolabadmin

Fungal infections are a serious public health problem, but unlike cancer and AIDS, they lack strong patient advocacy movements to raise awareness and secure funding. This paper argues that patients with fungal diseases have important insights about their care needs that could help improve policies and research if their voices were heard. The authors propose establishing unified advocacy organizations, like the MyCARE Foundation, to bring patients, doctors, and policymakers together to better address this neglected health challenge.

Read More »
Scroll to Top